Cargando…
Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocam...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186898/ https://www.ncbi.nlm.nih.gov/pubmed/21918544 http://dx.doi.org/10.1038/cddis.2011.79 |
_version_ | 1782213312998539264 |
---|---|
author | Noristani, H N Meadows, R S Olabarria, M Verkhratsky, A Rodríguez, J J |
author_facet | Noristani, H N Meadows, R S Olabarria, M Verkhratsky, A Rodríguez, J J |
author_sort | Noristani, H N |
collection | PubMed |
description | Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocampal CA1 in an AD triple transgenic mouse model (3xTg-AD). Here, we analyse the ultrastructural localisation, distribution and numerical density (N(v)) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-Te) and their relationship with SERT fibre sprouting and altered synaptic N(v) in 3xTg-AD compared with non-transgenic control mice. 3xTg-AD animals showed a significant increase in SERT-Te N(v) in CA1 at both, 3 (95%) and 18 months of age (144%), being restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced N(v) of perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the N(v) of symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te N(v) increase and PS reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efficacy as a response to the AD cognitive impairment. |
format | Online Article Text |
id | pubmed-3186898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-31868982011-11-21 Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study Noristani, H N Meadows, R S Olabarria, M Verkhratsky, A Rodríguez, J J Cell Death Dis Original Article Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocampal CA1 in an AD triple transgenic mouse model (3xTg-AD). Here, we analyse the ultrastructural localisation, distribution and numerical density (N(v)) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-Te) and their relationship with SERT fibre sprouting and altered synaptic N(v) in 3xTg-AD compared with non-transgenic control mice. 3xTg-AD animals showed a significant increase in SERT-Te N(v) in CA1 at both, 3 (95%) and 18 months of age (144%), being restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced N(v) of perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the N(v) of symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te N(v) increase and PS reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efficacy as a response to the AD cognitive impairment. Nature Publishing Group 2011-09 2011-09-15 /pmc/articles/PMC3186898/ /pubmed/21918544 http://dx.doi.org/10.1038/cddis.2011.79 Text en Copyright © 2011 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Original Article Noristani, H N Meadows, R S Olabarria, M Verkhratsky, A Rodríguez, J J Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title | Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title_full | Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title_fullStr | Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title_full_unstemmed | Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title_short | Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study |
title_sort | increased hippocampal ca1 density of serotonergic terminals in a triple transgenic mouse model of alzheimer's disease: an ultrastructural study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186898/ https://www.ncbi.nlm.nih.gov/pubmed/21918544 http://dx.doi.org/10.1038/cddis.2011.79 |
work_keys_str_mv | AT noristanihn increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy AT meadowsrs increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy AT olabarriam increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy AT verkhratskya increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy AT rodriguezjj increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy |